Procurement Summary
Country : Denmark
Summary : Information on the Conclusion of Amgros' Commissioning Agreements on Selected Medicines in 2025 Q2
Deadline : 19 May 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 117216787
Document Ref. No. : 220188-2025
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
This advance announcement is a briefing on Amgros' expected conclusion of commissioning agreements on covered medicines in section 3.1.Medicines to express interest in sending relevant information including price to tender@amgros.dk. AMGROS expects at a later date to offer the covered medicines as offered framework agreements on public tendering, and the expectation is that the tender will be published within theNext 12 months, but it will depend on more conditions. Even when the supply is published, Amgros will continue to enter into commissioning agreements on standard terms with interested parties, but from that time it will not be possible to negotiate terms, including price on the commissioning agreement. The finalTerms of tendering will appear in the tender material when it is published.
In relation to section 11.2, it is noted that the tender notice of the covered drugs will be published by publishing the tender and that the date in section 11.2 is only indicative.
Information on the conclusion of Amgros'Commissioning agreement on selected medicines in 2025 Q2
Expected purchasing value in the period of thisagreement...
Document Type: Prior Information Notice
Contract Type: Supplies
Authority Type: Body-Pl
Doc Title: Information on the conclusion of Amgros' In-use agreements on selected medicines in 2025 Q2
Dispatch Date: 2025-04-03
Publish Date: 2025-04-04
submission Date: 2025-05-19
Documents
Tender Notice